BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12434580)

  • 21. Effectiveness and tolerability of the herbal mixture Asparagus P on blood pressure in treatment-requiring antihypertensives.
    Chrubasik S; Droste C; Dragano N; Glimm E; Black A
    Phytomedicine; 2006 Nov; 13(9-10):740-2. PubMed ID: 16488123
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of diltiazem on lipid profiles and heart rate in hypertensive patients].
    Carré A; Joire JE; Mounier-Vehier C; Lequeuche B
    Ann Cardiol Angeiol (Paris); 1999 Mar; 48(3):221-6. PubMed ID: 12555384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effect of bromocriptine together with the established treatment for hypertension in patients undergoing peritoneal dialysis.
    Mejía-Rodríguez O; Alvarez-Aguilar C; Ledesma-Ramírez M; Paniagua-Sierra R
    Proc West Pharmacol Soc; 2004; 47():122-4. PubMed ID: 15633631
    [No Abstract]   [Full Text] [Related]  

  • 24. [Long-term treatment of hypertension with debrisoquin sulfate].
    Hammarström S
    Lakartidningen; 1970 Jun; 67(23):2663-8. PubMed ID: 5450560
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hypertension in the elderly].
    Rahn KH
    Internist (Berl); 1993 Dec; 34(12):1090-5. PubMed ID: 8106204
    [No Abstract]   [Full Text] [Related]  

  • 26. [Persistent orthostatic hypotonia following guanacline therapy].
    Bock KD; Heimsoth V
    Dtsch Med Wochenschr; 1969 Feb; 94(6):256-6 passim. PubMed ID: 5762679
    [No Abstract]   [Full Text] [Related]  

  • 27. Effectiveness and safety of eprosartan on pulse pressure for the treatment of hypertensive patients.
    Robles NR; Martín-Agueda B; López-Muñoz F; Alamo C;
    Int J Clin Pract; 2005 Apr; 59(4):478-84. PubMed ID: 15853868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Continuous automatic recording of blood pressure after administration of a new antihypertensive substance].
    Haan D
    Arzneimittelforschung; 1966 Sep; 16(9):1180-3. PubMed ID: 6014739
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical evaluation of indoramin as the sole agent for the treatment of hypertension.
    Kramer R; Rosendorff C; Bloom D
    S Afr Med J; 1974 Aug; 48(37):1569-72. PubMed ID: 4851044
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative evaluation of the antihypertensive activities of losartan and HM70186 during liver dysfunction.
    Lee S
    Arch Pharm Res; 2009 Jul; 32(7):965-6. PubMed ID: 19641875
    [No Abstract]   [Full Text] [Related]  

  • 31. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Double profit for hypertensive patients. Blood pressure decreases--frequency of coitus increases].
    MMW Fortschr Med; 2003 Aug; 145(33-34):56. PubMed ID: 14526578
    [No Abstract]   [Full Text] [Related]  

  • 33. [The safety of long-term administration of losartan in current clinical practice: a non-intervention NCT-CZ 14/04/LOZ study].
    Krupicka J; Ceypová K; Kristenová P; Hauser T
    Vnitr Lek; 2008 Nov; 54(11):1031-8. PubMed ID: 19069675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical experience with a new postganglionie blockader (Debriosquin, R0-5-3307)].
    Ocon Pujadas J
    Rev Clin Esp; 1972 Jun; 125(6):521-32. PubMed ID: 5074965
    [No Abstract]   [Full Text] [Related]  

  • 35. Nationwide efficacy-safety study of nebivolol in mildly hypertensive patients.
    Cleophas TJ; Agrawal R; Lichtenthal A; Mäkel W; Fici F
    Am J Ther; 2006; 13(3):192-7. PubMed ID: 16772759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of amlodipine and fosinopril on heart rate variability and left ventricular mass in mild-to-moderate essential hypertension.
    Bilge AK; Atilgan D; Tükek T; Ozcan M; Ozben B; Koylan N; Meriç M
    Int J Clin Pract; 2005 Mar; 59(3):306-10. PubMed ID: 15857327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study.
    Sharma AM; Wagner T; Marsalek P
    J Hum Hypertens; 2004 Sep; 18(9):669-75. PubMed ID: 15269705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [What's special about hypertension in the elderly?].
    Kreutz R; Scholze J
    MMW Fortschr Med; 2010 Nov; 152(47):31-4. PubMed ID: 21226374
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of an L- and N-type calcium channel blocker in hypertensive patients with neurovascular compression of the rostral ventrolateral medulla.
    Aota Y; Morimoto S; Sakuma T; Morita T; Jo F; Takahashi N; Maehara M; Ikeda K; Sawada S; Iwasaka T
    Hypertens Res; 2009 Aug; 32(8):700-5. PubMed ID: 19521420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
    Miyajima K; Minatoguchi S; Ito Y; Hukunishi M; Matsuno Y; Kakami M; Kawasaki M; Nishigaki K; Takemura G; Fujiwara H
    Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.